Biprogy Inc
TSE:8056
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 746
4 984
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Biprogy Inc
Current Assets | 164.6B |
Cash & Short-Term Investments | 42.3B |
Receivables | 83.4B |
Other Current Assets | 38.9B |
Non-Current Assets | 126.9B |
Long-Term Investments | 45.6B |
PP&E | 23.7B |
Intangibles | 35.3B |
Other Non-Current Assets | 22.2B |
Current Liabilities | 98.7B |
Accounts Payable | 24.1B |
Other Current Liabilities | 74.6B |
Non-Current Liabilities | 32.8B |
Long-Term Debt | 18.1B |
Other Non-Current Liabilities | 14.6B |
Balance Sheet
Biprogy Inc
Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
23 326
|
15 564
|
17 823
|
18 575
|
27 200
|
33 287
|
46 281
|
48 703
|
43 645
|
59 263
|
|
Cash Equivalents |
23 326
|
15 564
|
17 823
|
18 575
|
27 200
|
33 287
|
46 281
|
48 703
|
43 645
|
59 263
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
600
|
666
|
587
|
1 214
|
|
Total Receivables |
67 978
|
70 283
|
70 216
|
68 594
|
72 423
|
70 819
|
77 555
|
86 716
|
96 437
|
98 248
|
|
Accounts Receivables |
67 978
|
70 283
|
70 216
|
68 594
|
72 423
|
70 819
|
69 663
|
77 672
|
87 265
|
87 864
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
7 892
|
9 044
|
9 172
|
10 384
|
|
Inventory |
9 899
|
11 938
|
7 709
|
6 763
|
10 281
|
9 363
|
7 091
|
9 550
|
10 166
|
13 015
|
|
Other Current Assets |
21 370
|
24 735
|
22 507
|
16 526
|
18 366
|
19 828
|
11 746
|
12 421
|
13 815
|
16 174
|
|
Total Current Assets |
122 573
|
122 520
|
118 255
|
110 458
|
128 270
|
133 297
|
143 273
|
158 056
|
164 650
|
187 914
|
|
PP&E Net |
14 111
|
14 019
|
16 519
|
16 393
|
14 249
|
13 465
|
37 903
|
31 367
|
28 773
|
26 929
|
|
PP&E Gross |
14 111
|
14 019
|
16 519
|
16 393
|
14 249
|
13 465
|
37 903
|
31 367
|
28 773
|
26 929
|
|
Accumulated Depreciation |
40 100
|
38 520
|
35 819
|
38 221
|
39 850
|
42 377
|
40 523
|
42 312
|
42 767
|
42 667
|
|
Intangible Assets |
19 529
|
20 203
|
21 903
|
22 313
|
20 085
|
18 914
|
21 201
|
21 722
|
27 256
|
31 212
|
|
Goodwill |
1 797
|
920
|
836
|
753
|
1 288
|
1 509
|
1 873
|
1 589
|
1 906
|
1 926
|
|
Long-Term Investments |
18 024
|
15 616
|
17 983
|
23 354
|
23 926
|
23 329
|
37 546
|
45 148
|
47 666
|
47 635
|
|
Other Long-Term Assets |
23 738
|
19 816
|
17 198
|
24 007
|
23 603
|
24 461
|
12 239
|
10 765
|
10 145
|
18 603
|
|
Other Assets |
1 797
|
920
|
836
|
753
|
1 288
|
1 509
|
1 873
|
1 589
|
1 906
|
1 926
|
|
Total Assets |
199 772
N/A
|
193 094
-3%
|
192 694
0%
|
197 278
+2%
|
211 421
+7%
|
214 975
+2%
|
254 035
+18%
|
268 647
+6%
|
280 396
+4%
|
314 219
+12%
|
|
Liabilities | |||||||||||
Accounts Payable |
25 231
|
22 940
|
22 609
|
21 820
|
26 009
|
22 475
|
25 546
|
27 446
|
28 484
|
29 877
|
|
Accrued Liabilities |
7 689
|
8 922
|
9 985
|
10 532
|
11 155
|
10 905
|
0
|
0
|
0
|
0
|
|
Short-Term Debt |
4 000
|
475
|
6 350
|
1 350
|
1 050
|
0
|
0
|
0
|
100
|
2 400
|
|
Current Portion of Long-Term Debt |
15 115
|
17 593
|
11 421
|
5 963
|
5 661
|
6 028
|
12 888
|
14 308
|
10 453
|
12 784
|
|
Other Current Liabilities |
25 613
|
25 343
|
26 083
|
28 460
|
30 725
|
34 709
|
52 652
|
56 394
|
59 903
|
67 403
|
|
Total Current Liabilities |
77 648
|
75 273
|
76 448
|
68 125
|
74 600
|
74 117
|
91 086
|
98 148
|
98 940
|
112 464
|
|
Long-Term Debt |
36 742
|
19 515
|
21 054
|
21 789
|
17 113
|
16 236
|
34 552
|
27 542
|
27 451
|
20 360
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
18
|
262
|
679
|
323
|
|
Minority Interest |
587
|
569
|
560
|
1 302
|
1 544
|
1 633
|
1 715
|
1 757
|
1 710
|
1 890
|
|
Other Liabilities |
3 341
|
7 093
|
4 420
|
2 690
|
3 093
|
2 024
|
14 393
|
12 021
|
11 729
|
12 758
|
|
Total Liabilities |
118 384
N/A
|
102 450
-13%
|
102 482
+0%
|
93 906
-8%
|
96 350
+3%
|
94 010
-2%
|
141 764
+51%
|
139 730
-1%
|
140 509
+1%
|
147 795
+5%
|
|
Equity | |||||||||||
Common Stock |
5 485
|
5 489
|
5 483
|
5 483
|
5 483
|
5 483
|
5 483
|
5 483
|
5 483
|
5 483
|
|
Retained Earnings |
68 397
|
73 633
|
80 299
|
88 554
|
98 325
|
110 286
|
99 262
|
114 084
|
124 916
|
151 018
|
|
Additional Paid In Capital |
15 281
|
14 200
|
14 200
|
14 361
|
14 909
|
14 909
|
14 901
|
14 944
|
14 955
|
15 004
|
|
Unrealized Security Profit/Loss |
5 511
|
0
|
4 625
|
6 547
|
6 561
|
4 886
|
6 132
|
7 698
|
7 447
|
7 383
|
|
Treasury Stock |
19 283
|
0
|
13 592
|
13 578
|
13 540
|
13 513
|
13 475
|
13 400
|
13 315
|
13 226
|
|
Other Equity |
5 997
|
3 229
|
803
|
2 005
|
3 333
|
1 086
|
32
|
108
|
401
|
762
|
|
Total Equity |
81 388
N/A
|
90 644
+11%
|
90 212
0%
|
103 372
+15%
|
115 071
+11%
|
120 965
+5%
|
112 271
-7%
|
128 917
+15%
|
139 887
+9%
|
166 424
+19%
|
|
Total Liabilities & Equity |
199 772
N/A
|
193 094
-3%
|
192 694
0%
|
197 278
+2%
|
211 421
+7%
|
214 975
+2%
|
254 035
+18%
|
268 647
+6%
|
280 396
+4%
|
314 219
+12%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
94
|
107
|
100
|
100
|
100
|
100
|
100
|
100
|
101
|
101
|